Figure 3.

The association between prevalent genotypes of human papilloma virus persistent positivity and cervical cancer prognosis. HPV-16, -58, -52, -33 or multiple HPV persistent positivity were not associated with the survival times of CC patients (all P > 0.05). (all P > 0.05). However, the mean ± SD of the survival time for CC patients with HPV-18 persistent positivity (43.294 ± 2.978months) was significantly lower than that for CC patients with HPV-18 transient positivity or negativity (59.271 ± 0.415months), with P < 0.0001.